Xing‐Mai Jiang

1.3k citations
21 papers · 1.1k indexed · h-index 13
Topics
Platelet Disorders and Treatments (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)Endoplasmic Reticulum Stress and Disease (3 papers)

In The Last Decade

Xing‐Mai Jiang

21 papers receiving 1.1k citations

Peers

Xing‐Mai Jiang
Comparison fields: 5 of 96
  • Molecular Biology 580
  • Cell Biology 215
  • Physiology 166
  • Cancer Research 164
  • Immunology 140
Replace Zee-Fen Chang with:
Zee-Fen Chang Taiwan
Andrew J. Andrews United States
Elisabeth P.C. Kilsdonk Netherlands
Qingxiang Sun China
Christine Bordier France
Sérgio Lilla United Kingdom
Ryuichi Masaki Japan
Douglas A. Weidner United States
Martin Spitaler Austria
Christina H. Eng United States
Xing‐Mai Jiang relative to Zee-Fen Chang Taiwan Zee-Fen Chang's profile →
Citations per field
00.5×1.5×
Zee-Fen Chang · 1×
Citations per year

Countries citing papers authored by Xing‐Mai Jiang

Since Specialization
Citations

This map shows the geographic impact of Xing‐Mai Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing‐Mai Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing‐Mai Jiang more than expected).

Fields of papers citing papers by Xing‐Mai Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing‐Mai Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing‐Mai Jiang. The network helps show where Xing‐Mai Jiang may publish in the future.

Co-authorship network of co-authors of Xing‐Mai Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xing‐Mai Jiang. A scholar is included among the top collaborators of Xing‐Mai Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing‐Mai Jiang. Xing‐Mai Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 2
3 77
4 9
5 1
6 52
7 6
8 37
9 167
10 144
11 227
12 112
13 157
14 46
15 13
16 11
17 9
18 8
19 1
20 20

About Xing‐Mai Jiang

Xing‐Mai Jiang is a scholar working on Hematology, Cell Biology and Pharmacology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). The work is most often cited by research in Biochemistry (113 citations), Cell Biology (215 citations) and Virology (61 citations). Xing‐Mai Jiang has collaborated with scholars based in Australia, Canada and United Kingdom. Frequent co-authors include Philip J. Hogg, Patricia T. Yam, Neil Donoghue, Angelina J. Lay, Chris M. Grant, Melinda Fitzgerald, O. Kisker, Rosemary Condron, Evelyn Flynn and Niroshan Ramachandran. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026